Axsome Therapeutics (AXSM) Profit After Tax: 2022-2025
Historic Profit After Tax for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to -$47.2 million.
- Axsome Therapeutics' Profit After Tax rose 26.89% to -$47.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$229.5 million, marking a year-over-year increase of 26.19%. This contributed to the annual value of -$287.2 million for FY2024, which is 20.05% down from last year.
- Axsome Therapeutics' Profit After Tax amounted to -$47.2 million in Q3 2025, which was up 1.55% from -$48.0 million recorded in Q2 2025.
- Axsome Therapeutics' Profit After Tax's 5-year high stood at -$11.2 million during Q1 2023, with a 5-year trough of -$98.7 million in Q4 2023.
- In the last 3 years, Axsome Therapeutics' Profit After Tax had a median value of -$64.6 million in 2024 and averaged -$61.9 million.
- In the last 5 years, Axsome Therapeutics' Profit After Tax spiked by 71.69% in 2023 and then slumped by 509.35% in 2024.
- Axsome Therapeutics' Profit After Tax (Quarterly) stood at -$61.2 million in 2022, then crashed by 61.09% to -$98.7 million in 2023, then increased by 24.06% to -$74.9 million in 2024, then rose by 26.89% to -$47.2 million in 2025.
- Its Profit After Tax stands at -$47.2 million for Q3 2025, versus -$48.0 million for Q2 2025 and -$59.4 million for Q1 2025.